How to Verify a GLP-1 Provider in Five Minutes, Using Only Primary Sources
Five checks, all free, all primary sources, about five minutes. Every one requires the name of the fulfilling pharmacy — which is why a provider that will not name it has removed your only route to independent verification. Start there.
The five checks, in order of what they rule out
| # | Check | What it rules out | Where |
|---|---|---|---|
| 1 | Get the pharmacy name in writing | Everything below is impossible without it | The provider |
| 2 | State board licence lookup | An unlicensed or disciplined pharmacy | Each state board's register |
| 3 | FDA warning letters | A pharmacy with documented federal findings | FDA warning letter database |
| 4 | 503B registration | A false claim to outsourcing-facility status | FDA registered facilities list |
| 5 | Drug recall database | Recent recalls involving the firm | openFDA |
Steps 2 to 5 are searchable by company name and free.
What each check cannot tell you
- A licence in good standing is not a quality guarantee. It confirms the pharmacy is permitted to operate, not that a specific preparation is what it claims.
- No warning letter is not a clean record. It means no public federal action, which is a lower bar than it sounds.
- 503B registration is registration, not approval. The FDA does not approve compounded preparations from any facility.
- None of them tells you the salt form. Only the provider can, and only if asked.
The five questions to send in one email
- Which pharmacy fills this prescription, and is it 503A or 503B?
- What is the exact salt form and concentration, in mg/mL?
- Are there added ingredients — B12 or anything else — and at what concentration?
- What is the price at a maintenance dose, not the starting dose?
- What is refunded if I stop during titration?
Answers in writing to all five is a good sign. Answers to three of five tells you which two they would rather not put in writing, and that is information too.
Five minutes total against a decision costing $1,700 to $4,200 a year.
Why this matters more than any review score
A review score is someone's judgement. A state board register is a public record. When the two disagree, the register wins — and it is the one almost nobody checks, because it requires a name that most providers do not publish.
What the checks look like when they come back badly
| Finding | Severity | What it tells you |
|---|---|---|
| Pharmacy not named | Decisive | No independent check is possible |
| Licence expired or suspended | Decisive | The pharmacy is not permitted to operate |
| FDA warning letter, GLP-1 related | High | Documented federal findings on this category |
| FDA warning letter, unrelated | Moderate | Read what it was actually about |
| Claims 503B, not on the register | High | A verifiable false claim |
| Recent recall involving the firm | High | Check the product and the reason |
| Everything clean | Baseline | Necessary, not sufficient |
The last row matters: passing every check confirms permission to operate, not product quality.
Common questions
Is a provider with a warning letter automatically bad?
Read what it was about. Warning letters cover everything from labelling language to serious manufacturing findings, and the difference is substantial. A letter specifically about compounded GLP-1 preparations or salt forms is directly relevant; one about a marketing claim on an unrelated product is weaker evidence.
Why does the salt form question keep coming up?
Because it is the specific thing the FDA has objected to, and because it is invisible without asking. Semaglutide sodium and semaglutide acetate are not the same active ingredient as the base form in approved products. No licence check surfaces this — only the provider can answer it.
What if the pharmacy is licensed in a different state to me?
Normal. Pharmacies commonly hold non-resident licences to ship into other states, and that licence is also checkable on your own state's board register. What must be licensed in your state is the prescriber.
What a good answer looks like, verbatim
It is easier to recognise a sufficient answer than to describe one. These are the shapes worth looking for.
On the pharmacy: a name, a state, and a category. "Compounded by [Name] Pharmacy, a 503A pharmacy licensed in [State], non-resident licensed in yours." Everything checkable follows from that.
On formulation: "Semaglutide base, 2.5 mg/mL, no additional active ingredients." Base rather than a salt, a concentration in mg/mL, and an explicit statement about additives. If B12 or anything else is included, it should be named with its own concentration, because it was in no trial.
On price: "$X per month at every covered dose from 0.25 to 2.4 mg, no membership fee, billed monthly." A figure, a dose range in milligrams, an explicit statement about fees, and a billing term.
On refunds: "Cancel any time before the next fill; unshipped months refunded." Specific enough to hold them to.
The answers that should end the conversation
- "We work with a network of licensed pharmacies." Which one fills mine?
- "That is proprietary." The name is on the label of what arrives.
- "FDA-approved compounded semaglutide." No such thing exists — the FDA approves drugs, not compounded preparations, and does not approve pharmacies at all.
- "Pharmaceutical grade." Not a regulatory category. It means nothing.
- "Same as Ozempic." Only if it is base semaglutide, and even then the approved product's trials do not transfer to a compounded preparation.
| Phrase | Reality |
|---|---|
| "FDA-approved pharmacy" | The FDA does not approve pharmacies |
| "FDA-registered facility" | True of 503B facilities. Registration is not approval |
| "Pharmaceutical grade" | Not a regulatory category |
| "Clinically proven formula" | No compounded preparation has a trial of its own |
| "Physician-formulated" | Not a standard, and not a substitute for one |
None of these is illegal to say. All of them describe something other than what a reader hears.
Indicative of what we see across this market, on a five-point scale. The first row is the gate: without it, four of the five public checks cannot be run.
What this page does not settle
- Whether a specific preparation contains what it claims. No public database tells you that. Only a certificate of analysis from a named batch comes close, and few providers supply one.
- Whether a licensed pharmacy is a good pharmacy. A licence is permission to operate, not a quality rating.
- Whether the prescriber assessed you properly. That is visible from the intake, not from a register.
What the five checks do settle is whether the basic claims are true, and that is more than most buyers establish before spending two thousand dollars a year.